Prati
Marko Tomljanović
Marko Tomljanović
Asistent at Ruđer Bošković Institute, Laboratory for Epigenomics
Potvrđena adresa e-pošte na irb.hr
Naslov
Citirano
Citirano
Godina
Curcumin and its potential for systemic targeting of inflamm-aging and metabolic reprogramming in cancer
RN Kujundžić, V Stepanić, L Milković, AČ Gašparović, M Tomljanović, ...
International journal of molecular sciences 20 (5), 1180, 2019
292019
Lipid profile and aquaporin expression under oxidative stress in breast cancer cells of different malignancies
C Rodrigues, L Milkovic, IT Bujak, M Tomljanovic, G Soveral, ...
Oxidative medicine and cellular longevity 2019, 2019
232019
Oxidative stress and cancer heterogeneity orchestrate NRF2 roles relevant for therapy response
K Gall Trošelj, M Tomljanović, M Jaganjac, T Matijević Glavan, ...
Molecules 27 (5), 1468, 2022
212022
Nutritional stress in head and neck cancer originating cell lines: The sensitivity of the NRF2-NQO1 axis
L Milković, M Tomljanović, A Čipak Gašparović, R Novak Kujundžić, ...
Cells 8 (9), 1001, 2019
192019
Nicotinamide N-methyltransferase in acquisition of stem cell properties and therapy resistance in cancer
R Novak Kujundžić, M Prpić, N Đaković, N Dabelić, M Tomljanović, ...
International journal of molecular sciences 22 (11), 5681, 2021
172021
Implementing curcumin in translational oncology research
KG Trošelj, I Samaržija, M Tomljanović, RN Kujundžić, N Đaković, ...
Molecules 25 (22), 5240, 2020
132020
EZH2 inhibition and cisplatin as a combination anticancer therapy: an overview of preclinical studies
I Samaržija, M Tomljanović, R Novak Kujundžić, KG Trošelj
Cancers 14 (19), 4761, 2022
122022
Cell-type specific metabolic response of cancer cells to curcumin
A Mojzeš, M Tomljanović, L Milković, R Novak Kujundžić, ...
International journal of molecular sciences 21 (5), 1661, 2020
122020
Various EZH2 transcript variants are present in cancer cell lines
M Tomljanović, L Milković, A Čipak Gašparović, R Novak Kujundžić, ...
Chromatin and Epigenetics, 156-156, 2019
2019
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–9